Medtronic, Inc. · Minneapolis, MN United States (NYSE: MDT)
Key Medtronic, Inc. Financials
| Company Type | Public -(NYSE: MDT) Headquarters |
|---|---|
| Fiscal Year-End | April |
| 2011 Sales (mil.) | $15,933.0 |
| 2011 Employees | 45,000 |
Medtronic, Inc. Stock Quote (NYSE: MDT)
| Latest 02/15/12 12:09:11 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $39.57 |  0.040 | 0.100 | $39.74 | $39.42 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Medtronic, Inc. Income Statement
| Apr 11 | Apr 10 | Apr 09 | |
| Revenue | 15,933.0 | 15,817.0 | 14,599.0 |
| Cost of Goods Sold | 3,912.0 | 3,812.0 | 3,518.0 |
| Gross Profit | 12,021.0 | 12,005.0 | 11,081.0 |
| Gross Profit Margin | 75.4% | 75.9% | 75.9% |
| SG&A Expense | 5,533.0 | 5,789.0 | 5,152.0 |
| Depreciation & Amortization | 804.0 | 772.0 | 699.0 |
| Operating Income | 3,723.0 | 3,969.0 | 2,594.0 |
| Operating Margin | 23.4% | 25.1% | 17.8% |
| Nonoperating Income | -- | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 3,723.0 | 3,969.0 | 2,594.0 |
| Income Taxes | 627.0 | 870.0 | 425.0 |
| Net Income After Taxes | 3,096.0 | 3,099.0 | 2,169.0 |
| Continuing Operations | 3,096.0 | 3,099.0 | 2,169.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 3,096.0 | 3,099.0 | 2,169.0 |
| Total Net Income | 3,096.0 | 3,099.0 | 2,169.0 |
| Net Profit Margin | 19.4% | 19.6% | 14.9% |
| Diluted EPS from Total Net Income | 2.86 | 2.79 | 1.93 |
| Dividends per Share | 0.90 | 0.82 | 0.75 |
All amounts in millions of US Dollars except per share amounts.
Medtronic, Inc. Balance Sheet
| Assets | Apr 11 | Apr 10 | Apr 09 |
| Current Assets | |||
| Cash | 1,382.0 | 1,400.0 | 1,271.0 |
| Net Receivables | 3,822.0 | 3,335.0 | 3,123.0 |
| Inventories | 1,695.0 | 1,481.0 | 1,426.0 |
| Other Current Assets | 2,218.0 | 3,623.0 | 1,640.0 |
| Total Current Assets | 9,117.0 | 9,839.0 | 7,460.0 |
| Net Fixed Assets | 2,511.0 | 2,421.0 | 2,279.0 |
| Other Noncurrent Assets | 18,796.0 | 15,830.0 | 13,922.0 |
| Total Assets | 30,424.0 | 28,090.0 | 23,661.0 |
| Liabilities | Apr 11 | Apr 10 | Apr 09 |
| Current Liabilities | |||
| Accounts Payable | 511.0 | 420.0 | 382.0 |
| Short-Term Debt | 1,723.0 | 2,575.0 | 522.0 |
| Other Current Liabilities | 2,480.0 | 2,126.0 | 2,243.0 |
| Total Current Liabilities | 4,714.0 | 5,121.0 | 3,147.0 |
| Long-Term Debt | 8,112.0 | 6,944.0 | 6,772.0 |
| Other Noncurrent Liabilities | 1,630.0 | 1,396.0 | 891.0 |
| Total Liabilities | 14,456.0 | 13,461.0 | 10,810.0 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | -- | 0.0 |
| Common Stock Equity | 15,968.0 | 14,629.0 | 12,851.0 |
| Total Equity | 15,968.0 | 14,629.0 | 12,851.0 |
| Shares Outstanding (thou.) | 1,070,162.1 | 1,097,342.6 | 1,119,284.1 |
All amounts in millions of US Dollars except per share amounts.
Medtronic, Inc. Cash Flow Statement
| Apr 11 | Apr 10 | Apr 09 | |
| Net Operating Cash Flow | 3,741 | 4,131 | 3,878 |
| Net Investing Cash Flow | (1,815.0) | (4,759.0) | (2,740.0) |
| Net Financing Cash Flow | (2,006.0) | 764.0 | (845.0) |
| Net Change in Cash | (18.0) | 129.0 | 211.0 |
| Depreciation & Amortization | 804.0 | 772.0 | 699.0 |
| Capital Expenditures | (548.0) | (635.0) | (663.0) |
| Cash Dividends Paid | (969.0) | (907.0) | (843.0) |
All amounts in millions of US Dollars except per share amounts.